Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Pediatric Hematology
•
Critical Care
Does continuous platelet transfusion reduce platelet refractoriness in ECMO?
Related Questions
What is your standard diagnostic workup to confirm GVHD in a patient post-BMT with skin rash and jaundice?
What is your preferred strategy for young adults with ITP complicated by recurrent autoimmune neutropenia?
What is your preferred treatment for refractory warm autoimmune hemolytic anemia with autoimmune neutropenia?
How do you counsel an otherwise healthy patient on how soon they can go back to moderate exercise after a bilateral pulmonary embolism?
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
What diagnostic workup is recommended when immune thrombocytopenia is present in multiple family members?
How would you manage HHT with ongoing epistaxis despite IV bevacizumab, with a history of superficial thrombosis?
What is your approach to an infant (<12 mo) with new onset petechiae and thrombocytopenia, with labs consistent with ITP?
For pediatric patients with iron overload (high ferritin and transferrin saturation), do you perform HFE screening first, or proceed to non-HFE gene sequencing upfront to evaluate for HJV mutation as well?
What are your top takeaways in Classical Hematology from ASH 2025?
